Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHA:600721)

China flag China · Delayed Price · Currency is CNY
9.26
-0.01 (-0.11%)
Feb 27, 2026, 3:00 PM CST
Market Cap3.56B +46.4%
Revenue (ttm)393.73M -0.1%
Net Income50.20M +161.0%
EPS0.13 +159.8%
Shares Out384.55M
PE Ratio70.92
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,588,009
Average Volume11,727,440
Open9.28
Previous Close9.27
Day's Range9.20 - 9.29
52-Week Range5.97 - 12.60
Beta0.21
RSI42.51
Earnings DateMar 28, 2026

About SHA:600721

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. It also offers comprehensive contract research organization (CRO) solutions, including one-stop, full-process services for drug R&D, such as Phase I to IV clinical trials, bioequivalence and pharmacokinetics testing, medical science services, R&D project consulting, data management and statistical services, and third-party testing, which covers biological sample analysis, packagi... [Read more]

Industry Restaurants
Founded 1959
Employees 578
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600721
Full Company Profile

Financial Performance

In 2024, SHA:600721's revenue was 385.76 million, an increase of 4.46% compared to the previous year's 369.28 million. Earnings were 41.48 million, an increase of 219.75%.

Financial Statements